[PDF][PDF] Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response.

LJ Ayash, JE Wright, O Tretyakov, R Gonin… - Journal of Clinical …, 1992 - researchgate.net
Background: Cyclophosphamide, which forms the nucleus for virtually all preparative
regimens for autologous bone marrow transplantation (ABMT), is an alkylating cagent of which …

Stereoselective metabolism of ifosfamide by human P-450s 3A4 and 2B6. Favorable metabolic properties of R-enantiomer

P Roy, O Tretyakov, J Wright, DJ Waxman - Drug metabolism and disposition, 1999 - ASPET
The anticancer prodrug ifosfamide (IFA) contains a chiral phosphorous atom and is
administered clinically as a racemic mixture ofR and S enantiomers. Animal model studies and …

Antitumor efficacy and pharmacokinetic analysis of 4-hydroperoxycyclophosphamide in comparison with cyclophosphamide±hepatic enzyme effectors

…, SA Holden, DA Goff, JE Wright, O Tretyakov… - Cancer chemotherapy …, 1996 - Springer
4-Hydroperoxycyclophosphamide is an oxazaphosphorine which is readily converted
without enzymatic involvement to 4-hydroxycyclophosphamide – a key intermediate in the …

High-dose ifosfamide, carboplatin, and etoposide pharmacokinetics: correlation of plasma drug levels with renal toxicity

JE Wright, A Elias, O Tretyakov, S Holden… - Cancer chemotherapy …, 1995 - Springer
An autologous bone marrow transplant regimen of ifosfamide, carboplatin, and etoposide (ICE)
has been developed as treatment for certain malignancies. At maximum tolerated doses …

Analysis of 4-hydroxycyclophosphamide in human blood

JE Wright, O Tretyakov, LJ Ayash, A Elias… - Analytical …, 1995 - Elsevier
Cyclophosphamide is a prodrug activated by cytochrome P450 isozymes in the liver. The
product of hepatic activation of cyclophosphamide is 4-hydroxycyclophosphamide. Previously …

Dose escalation of N, N', N"-triethylenethiophosphoramide combined with pentoxifylline for advanced breast cancer.

CL Shapiro, BJ Dezube, O Tretyakov, J Wright… - Clinical cancer research …, 1995 - AACR
Dose Escalation of N,N’,N’ ‘-Triethylenethiophosphoramide Combined with Pentoxifylline for
Advanced Breast Cancer1 Page 1 Vol. 1, 791-796, August 1995 Clinical Cancer Research …

[HTML][HTML] Structure and properties of epoxy polysulfone systems modified with an active diluent

TV Petrova, IV Tretyakov, AV Kireynov, AV Shapagin… - Polymers, 2022 - mdpi.com
An epoxy resin modified with polysulfone (PSU) and active diluent furfuryl glycidyl ether (FGE)
was studied. Triethanolaminotitanate (TEAT) and iso-methyltetrahydrophthalic anhydride (…

[HTML][HTML] Improvement of the Structure and Physicochemical Properties of Polylactic Acid Films by Addition of Glycero-(9, 10-trioxolane)-Trialeate

…, M Konstantinova, V Podmasterev, I Tretyakov… - Polymers, 2022 - mdpi.com
Glycero-(9,10-trioxolane)-trioleate (ozonide of oleic acid triglyceride, OTOA) was introduced
into polylactic acid (PLA) films in amounts of 5, 10, 30, 50, and 70% w/w. The morphological, …

“Jumping Crystals”: Oxygen-Evolving Metal-Nitroxide Complexes

…, EY Fursova, OV Kuznetsova, EV Tretyakov… - Inorganic …, 2011 - ACS Publications
The crystals of heterospin complexes [M(hfac) 2 L 2 ] (where M = Cu, Ni, Co, or Mn; hfac =
hexafluoroacetylacetonate; and L = nitronyl nitroxide, 4,4,5,5-tetramethyl-2-(1-methyl-1H-…

Synthesis, structure and magnetism of M (hfac) 2 complexes with spin labelled amides

EV Tretyakov, OV Koreneva, GV Romanenko… - Polyhedron, 2004 - Elsevier
An effective method for the synthesis of 4,4,5,5-tetramethyl-3-oxide-1-oxyl-4,5-dihydro-1H-imidazole-2-carbonitrile
(1) has been found. 4,4,5,5-Tetramethyl-3-oxide-1-oxyl-4,5-dihydro-…